AGENAS calls for voluntary contribution for several HTA projects

26

Feb 2019

As part of the Ministry of Health and AGENAS agreement "Technological innovation, productivity, monitoring of consumption and costs according to an HTA (Health Technology Assessment) model," AGENAS will soon carry out the assessment of several medical devices and procedures.

Thus, in early February 2019, AGENAS has called for the voluntary contribution of the clinical experts and/or reviewers, as well as for the contribution of the manufacturers has announced that they’re working on several HTA projects. The voluntary reviewers will join the project soon, while in March 2019, the manufacturers will provide their contribution.

The contribution is requested for the following topics: The following topics are to be assessed:

  • Bariatric surgery for patients with type 2 diabetes regardless of body mass index – adapted HTA
  • Eversense XL CGM system: Continuous glucose monitoring (CGM real-time) in patients with diabetes mellitus treated with insulin – adapted HTA
  • Elecsys®sFlt-1/PlGF (Preeclampsia): test in preeclampsia diagnosis – horizon scanning report
  • SIRIO H3: virtual navigation system to support radiological procedures with percutaneous access - horizon scanning report
  • Elekta Unity: Adaptive radiotherapy with the combination of MR imaging and linear accelerator (linac) - horizon scanning report

Interested parties should send an email to hta@agenas.it, with accompanied by the CV and the attached disclosure statement and confidentiality agreement duly filled, indicating the role they’re applying for. The selection process will be done according to the AGENAS HTA manual. The deadline is February 28, 2019.

The same is valid for the manufacturers, but they are also invited to the headquarters of AGENAS, in Rome, to discuss these devices in person:

  • Elecsys® - March 19, 2019, 11:30h – 13h
  • SIRIO H3 – March 21, 2019, 11:30h – 13h
  • Eversense XL CGM system – March 26, 2019,  11:30h – 13h
  • Elekta Unity – March 28, 2019, 11:30h – 13h

See all details, with the declaration on the conflict of interest and privacy, here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

26

Jul 2021

The revised EBM (German Uniform Evaluation Standard) catalog came into force on July 1, 2021. Three biomarker tests in breast cancer, a number of services related to cryopreservation of egg and sperm cells in young cancer patients, new services dedicated to prenatal testing of the fetal rhesus factor, services concerning the delivery of brachytherapy in prostate cancer were introduced.

Read more

20

Jul 2021

On June 30, 2021, the Interterritorial Council of the National Health System has approved the inclusion of real-time continuous glucose monitoring (rt-CGM) systems in the Common Package of Benefits for adult patients meeting certain criteria. The inclusion of rt-CGM devices in the Common Package of Benefits means that these devices are now guaranteed to the defined population nationwide.

Read more

16

Jul 2021

In June 2021, the National Institute for Health Research (NIHR) in England released six MedTech-related reports in its Health Technology Assessment (HTA) Journal, which concerned tibial nerve stimulation for urinary incontinence treatment, imaging in ophthalmology, in-vitro diagnostics, and eHealth. HTA Journal publishes research reports on the effectiveness, costs, and broader impact of health technologies for those who use, manage, and provide care in the NHS, and informs National Institute for Health and Care Excellence (NICE) guidance.

Read more

06

Jul 2021

In June 2021, the National Institute for Health and Care Excellence (NICE) published two new Interventional Procedure Guidance (laser lithotripsy for difficult-to-treat bile duct stones and percutaneous insertion of a closure device to repair a paravalvular leak around a replaced mitral or aortic valve), one new Medical Technologies Guidance (Plus Sutures for preventing surgical site infection), and four new Medtech Innovation Briefings (RapidAI for analyzing CT/MRI brain scans, WoundExpress, Magtrace and Sentimag, and SYNE-COV). Also, four clinical guidelines were updated, and two new published.

Read more

05

Jul 2021

On July 1, 2021, the updated version of the Swiss Services Ordinance (KLV/OPre) came into force. The changes concern the List of explicitly evaluated services (Annex 1 of KLV/OPre), the List of medical aids (Annex 2 of KLV/OPre), and the List of Analyses (Annex 3 of KLV/OPre).

Read more